Vasculitis: Contemporary perspectives

Comprehensive Therapy

Volumn 32, Issue 2, 2006, Pages 118-126

  Krishnamurthy, Anita ^a   Naguwa, Stanley M ^a   Cheema, Gurtej S ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GAMMA GLOBIN; GLUCOCORTICOID; IMMUNOGLOBULIN; METHOTREXATE;

ALLERGIC VASCULITIS; ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; CRYOGLOBULINEMIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG MEGADOSE; GIANT CELL ARTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LABORATORY TEST; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHYSICAL EXAMINATION; PLASMAPHERESIS; POLYARTERITIS NODOSA; POSITRON EMISSION TOMOGRAPHY; RELAPSE; REMISSION; REVIEW; SKIN BIOPSY; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; ANTINEOPLASTIC AGENTS; CHILD; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; VASCULITIS;

EID: 33746412968     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1385/COMP:32:2:118     Document Type: Review

References (20)

1. Langford CA. Vasculitis. J Allergy Clin Immunol 2003;111(2 Suppl):S602-612.
2. Luqmani RA, Robinson H. Introduction to, and classification of, the systemic vasculitides. Best Pract Res Clin Rheumatol 2001;15(2):187-202.
3. Scott DG, Watts RA. Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis 2000;59(3):161-163.
4. Lane SE, Watts R, Scott DG. Epidemiology of systemic vasculitis. Curr Rheumatol Rep 2005;7(4):270-275.
5. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitides. Best Pract Res Clin Rheumatol 2002;16(5):833-845.
6. Roane DW, Griger DR. An approach to diagnosis and initial management of systemic vasculitis. Am Fam Physician 1999;60(5):1421-1430.
7. Mohan N, Kerr GS. Diagnosis of vasculitis. Best Pract Res Clin Rheumatol 2001;15(2):203-223.
8. Buhaescu I, Covic A, Levy J. Systemic vasculitis: still a challenging disease. Am J Kidney Dis 2005;46(2):173-185.
9. Watts RA, Scott DG, Pusey CD, Lockwood CM. Vasculitis - aims of therapy. An overview. Rheumatology (Oxford) 2000;39(3):229-232.
10. Langford CA. Wegener's granulomatosis: current and upcoming therapies. Arthritis Res Ther 2003;5(4):180-191.
11. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42(3):421-430.
12. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet 15 2003;361(9357):587-594.
13. Gross WL. Churg-Strauss syndrome: update on recent developments. Curr Opin Rheumatol 2002;14(1):11-14.
14. Barron KS, Shulman ST, Rowley A, et al. Report of the National Institutes of Health Workshop on Kawasaki Disease. J Rheumatol 1999;26(1):170-190.
15. Schmidt WA, Gromnica-Ihle E. What is the best approach to diagnosing large-vessel vasculitis? Best Pract Res Clin Rheumatol 2005;19(2):223-242.
16. Penn H, Dasgupta B. Giant cell arteritis. Autoimmun Rev 2003;2(4):199-203.
17. Nordborg E, Nordborg C. Giant cell arteritis: strategies in diagnosis and treatment. Curr Opin Rheumatol 2004;16(1):25-30.
18. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 2005;17(1):16-24.
19. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med 1994;120(11):919-929.
20. Noble J. Textbook of Primary Care Medicine, 3rd ed. Philadelphia: Mosby; 2001.